Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (23769)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 7, 2015 (publication date) through Jul 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Usami M, Miyoshi M, Yamashita H. Gut microbiota and host metabolism in liver cirrhosis. World J Gastroenterol 2015; 21(41): 11597-11608 [PMID: 26556989 DOI: 10.3748/wjg.v21.i41.11597] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i41/11597.htm |
| Number | Citing Articles |
| 1 |
Maria S. Zhigalova, Vladimir V. Kiselev, Alla A. Ryk, Petr A. Yartsev. Nutritional deficiency in patients with liver cirrhosis. Clinical nutrition and metabolism 2023; 4(4): 265 doi: 10.17816/clinutr629043
|
| 2 |
Naim Alkhouri, Carl LaCerte, Jeffrey Edwards, Fred Poordad, Eric Lawitz, Lois Lee, Sharon Karan, Sangeeta Sawhney, Mary Erickson, Leigh MacConell, Luna Zaru, Jianfen Chen, Jason Campagna. Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH. Liver International 2024; 44(4): 966 doi: 10.1111/liv.15816
|
| 3 |
Jiachen Liu, Yantao Xu, Bimei Jiang. Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.586427
|
| 4 |
Yumeng Zhang, Min Zhao, Xue Jiang, Qiaoyu Qiao, Tingting Liu, Chunjie Zhao, Miao Wang. Comprehensive Analysis of Fecal Microbiome and Metabolomics in Hepatic Fibrosis Rats Reveal Hepatoprotective Effects of Yinchen Wuling Powder From the Host-Microbial Metabolic Axis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.713197
|
| 5 |
Vanessa Stadlbauer, Irina Komarova, Ingeborg Klymiuk, Marija Durdevic, Alexander Reisinger, Andreas Blesl, Florian Rainer, Angela Horvath. Disease severity and proton pump inhibitor use impact strongest on faecal microbiome composition in liver cirrhosis. Liver International 2020; 40(4): 866 doi: 10.1111/liv.14382
|
| 6 |
Alejandra Altamirano-Barrera, Misael Uribe, Norberto C. Chávez-Tapia, Natalia Nuño-Lámbarri. The role of the gut microbiota in the pathology and prevention of liver disease. The Journal of Nutritional Biochemistry 2018; 60: 1 doi: 10.1016/j.jnutbio.2018.03.006
|
| 7 |
Gh Jeelani Mir, Nissar Ul Ashraf. Gut Microbiota Dysbiosis in the Pathogenesis of Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD). The International Journal of Gastroenterology and Hepatology Diseases 2024; 3 doi: 10.2174/0126662906299478240614100954
|
| 8 |
Wenlin Chen, Fang Liang, Yue Zhang, Yuncheng Zhang, Jinzhen Lv, Xiande Jin, Yun Ran, Shenghui Li, Wen Sun. Metagenome-based characterization of the gut bacteriome, mycobiome, and virome in patients with chronic hepatitis B-related liver fibrosis. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1449090
|
| 9 |
Andrea Mancini, Francesca Campagna, Piero Amodio, Kieran M. Tuohy. Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy. Food & Function 2018; 9(3): 1373 doi: 10.1039/C7FO01528C
|
| 10 |
Anju Thomas, Kalainathan Sivaperuman. Chemical spray pyrolysis deposited ZnO/ZIF-8 and cobalt doped ZnO/ZIF-8 composite thin films for highly sensitive and selective ammonia sensing at room temperature. Surfaces and Interfaces 2024; 54: 105241 doi: 10.1016/j.surfin.2024.105241
|
| 11 |
Chaoqun Li, Beili Zhang, Xin Wang, Xionge Pi, Xuan Wang, Huihui Zhou, Kangsen Mai, Gen He. Improved utilization of soybean meal through fermentation with commensal Shewanella sp. MR-7 in turbot (Scophthalmus maximus L.). Microbial Cell Factories 2019; 18(1) doi: 10.1186/s12934-019-1265-z
|
| 12 |
Patricia P. Bloom, Jesús M. Luévano, Kelsey J. Miller, Raymond T. Chung. Deep stool microbiome analysis in cirrhosis reveals an association between short-chain fatty acids and hepatic encephalopathy. Annals of Hepatology 2021; 25: 100333 doi: 10.1016/j.aohep.2021.100333
|
| 13 |
Cyriac Abby Philips, Philip Augustine, Praveen Kumar Yerol, Ganesh Narayan Ramesh, Rizwan Ahamed, Sasidharan Rajesh, Tom George, Sandeep Kumbar. Modulating the Intestinal Microbiota: Therapeutic Opportunities in Liver Disease. Journal of Clinical and Translational Hepatology 2019; (X): 1 doi: 10.14218/JCTH.2019.00035
|
| 14 |
Владимир Александрович Карпин, Ольга Ивановна Шувалова. INTESTINAL MICROBIOTA AND LIVER AND KIDNEY DISEASES. Перспективные исследования в психологии, спорте и здравоохранении: сборник статей международной научной конференции (Санкт-Петербург, Май 2024) 2024; : 39 doi: 10.58351/240528.2024.39.50.003
|
| 15 |
Yi Shao, Yuancong Jiang, Hui Li, Feng Zhang, Zhenhua Hu, Shusen Zheng. Characteristics of mouse intestinal microbiota during acute liver injury and repair following 50% partial hepatectomy. Experimental and Therapeutic Medicine 2021; 22(3) doi: 10.3892/etm.2021.10385
|
| 16 |
Kexin Tao, Han Peng, Xin Bi, Xiaoya Wang, Yue Tian, Hua Zhang, Yong Sun. Effect of Tetrastigma hemsleyanum leaves and Extract supplementation on liver metabolomics and the gut microbiota in alcohol-induced liver injury. Food Bioscience 2024; 58: 103617 doi: 10.1016/j.fbio.2024.103617
|
| 17 |
Ruipeng Zheng, Guoqiang Wang, Zhiqiang Pang, Nan Ran, Yinuo Gu, Xuewa Guan, Yuze Yuan, Xu Zuo, He Pan, Jingtong Zheng, Fang Wang. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma. Cancer Medicine 2020; 9(12): 4232 doi: 10.1002/cam4.3045
|
| 18 |
Haifeng Lu, Liang Chen, Xiaxia Pan, Yujun Yao, Hua Zhang, Xiaofei Zhu, Xiaobin Lou, Chunxia Zhu, Jun Wang, Lanjuan Li, Zhongwen Wu. Lactitol Supplementation Modulates Intestinal Microbiome in Liver Cirrhotic Patients. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.762930
|
| 19 |
Xinyi Gu, Shuwei Li, Mengna Lu, Ying Li, Qixue Wang, Long Chen, Yiqun Jia, Shan Cao, Ting Zhang, Mingmei Zhou, Xiaojun Gou. Investigation of Gynura segetum root extract (GSrE) induced hepatotoxicity based on metabolomic signatures and microbial community profiling in rats. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.947757
|
| 20 |
Yiwen Li, Mengmeng Zhu, Yanfei Liu, Binyu Luo, Jing Cui, Luqi Huang, Keji Chen, Yue Liu. The oral microbiota and cardiometabolic health: A comprehensive review and emerging insights. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1010368
|
| 21 |
Qiang Wang, Chengxin Chen, Shi Zuo, Kun Cao, Haiyang Li. Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04262-9
|
| 22 |
Miwa Katagiri, Makoto Kuroda, Tsuyoshi Sekizuka, Norihide Nakada, Yukitaka Ito, Masanobu Otsuka, Manabu Watanabe, Shinya Kusachi. Comprehensive Genomic Survey of Antimicrobial-Resistance Bacteria in the Sewage Tank Replacement with Hospital Relocation. Infection and Drug Resistance 2021; : 5563 doi: 10.2147/IDR.S336418
|
| 23 |
M. D. Akhmedova, G. Yu. Sultonova, A. M.-T. Bektimirov, A. N. Barinova. The state of intestinal microflora in patients with cirrhosis of the liver of viral etiology and the correction of its treatment. HIV Infection and Immunosuppressive Disorders 2021; 13(1): 97 doi: 10.22328/2077-9828-2021-13-1-97-105
|
| 24 |
Xia-Yu Jiang, Xin Peng, Cheng Liu, Jin-Hui Liu, Ye Yang, Shuang-Shuang Zhai. Curcumin attenuates liver inflammation in ducks fed corn contaminated with ochratoxin A possibly by regulating intestinal microbiota and inhibiting toll like receptor 4/nuclear factor kappa-B signaling pathway. Livestock Science 2023; 277: 105345 doi: 10.1016/j.livsci.2023.105345
|
| 25 |
Maria Adriana Neag, Adrian Catinean, Dana Maria Muntean, Maria Raluca Pop, Corina Ioana Bocsan, Emil Claudiu Botan, Anca Dana Buzoianu. Probiotic Bacillus Spores Protect Against Acetaminophen Induced Acute Liver Injury in Rats. Nutrients 2020; 12(3): 632 doi: 10.3390/nu12030632
|
| 26 |
Farnaz Yousefi, Brett Sponseller, Muhammed Shafeekh Muyyarikkandy, Neha Praveen, Michael W. Greene, Shankumar Mooyottu. Clostridioides difficile infection induces a pro-inflammatory and pro-steatotic metabolic state in liver. npj Gut and Liver 2025; 2(1) doi: 10.1038/s44355-024-00016-6
|
| 27 |
Naqash Alam, Xinhua Ding, Yu Fu, Linying Jia, Sadiq Ali, Enqi Liu. Oryzanol ameliorates MCD-induced metabolic dysfunction-associated steatohepatitis in mice via gut microbiota reprogramming and TLR4/NF-κB signaling suppression. American Journal of Physiology-Gastrointestinal and Liver Physiology 2025; 328(5): G578 doi: 10.1152/ajpgi.00190.2024
|
| 28 |
Hao Zhang, Ani Yan, Xiaoyun Liu, Yi Ma, Fangfang Zhao, Mengzhi Wang, Jaun J. Loor, Hongrong Wang. Melatonin ameliorates ochratoxin A induced liver inflammation, oxidative stress and mitophagy in mice involving in intestinal microbiota and restoring the intestinal barrier function. Journal of Hazardous Materials 2021; 407: 124489 doi: 10.1016/j.jhazmat.2020.124489
|
| 29 |
Xin Chen, Wenying Qiu, Xuqian Ma, Linli Ren, Mingqian Feng, Sheng Hu, Chang Xue, Runzhi Chen. Roles and Mechanisms of Choline Metabolism in Nonalcoholic Fatty Liver Disease and Cancers. Frontiers in Bioscience-Landmark 2024; 29(5) doi: 10.31083/j.fbl2905182
|
| 30 |
Daniela Campion, Ilaria Giovo, Paola Ponzo, Giorgio M Saracco, Federico Balzola, Carlo Alessandria. Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis. World Journal of Hepatology 2019; 11(6): 489-512 doi: 10.4254/wjh.v11.i6.489
|
| 31 |
Hongying Cai, Daojie Li, Liye Song, Xin Xu, Yunsheng Han, Kun Meng, Zhiguo Wen, Peilong Yang. Metabolomic Characteristics of Liver and Cecum Contents in High-Fat-Diet-Induced Obese Mice Intervened with Lactobacillus plantarum FRT10. Foods 2022; 11(16): 2491 doi: 10.3390/foods11162491
|
| 32 |
Thomas Malikowski, Sahil Khanna, Darrell S. Pardi. Fecal microbiota transplantation for gastrointestinal disorders. Current Opinion in Gastroenterology 2017; 33(1): 8 doi: 10.1097/MOG.0000000000000326
|
| 33 |
Lezhen Dong, Chuan Qin, Ying Li, Zufang Wu, Lianliang Liu. Oat phenolic compounds regulate metabolic syndrome in high fat diet-fed mice via gut microbiota. Food Bioscience 2022; 50: 101946 doi: 10.1016/j.fbio.2022.101946
|
| 34 |
Takashi Himoto, Tsutomu Masaki. Current Trends of Essential Trace Elements in Patients with Chronic Liver Diseases. Nutrients 2020; 12(7): 2084 doi: 10.3390/nu12072084
|
| 35 |
Bingxian Liu, Qiwen Zeng, Hanming Chen, Jianzhao Liao, Yuman Bai, Qingyue Han, Na Qiao, Shuzhou Wang, Khalid Mehmood, Riaz Hussain, Bhutto Zohaib Ahmed, Zhaoxin Tang, Hui Zhang, Ying Li. The hepatotoxicity of altrazine exposure in mice involves the intestinal microbiota. Chemosphere 2021; 272: 129572 doi: 10.1016/j.chemosphere.2021.129572
|
| 36 |
Tadele Ageru Alemu, Delele Worku Ayele, Dhakshnamoorthy Mani, Ababay Ketema Worku, Minbale Admas Teshager, Tessera Alemneh Wubieneh, Addisu Alemayehu Assegie, Solomon Demiss Negedu, Melese Yalew Ayalew, Praveen C Ramamurthy, J. Shahitha Praveen. Novel Ag-Doped- Poly (aniline-co-pyrrole)/Titanium-Dioxide Nanocomposite Sensor Material for Ammonia Detection in Spoiled Meat. Journal of The Electrochemical Society 2024; 171(10): 107509 doi: 10.1149/1945-7111/ad83f8
|
| 37 |
Stephen D. H. Malnick, David Fisher, Marina Somin, Manuela G. Neuman. Treating the Metabolic Syndrome by Fecal Transplantation—Current Status. Biology 2021; 10(5): 447 doi: 10.3390/biology10050447
|
| 38 |
David Porras, Esther Nistal, Susana Martínez-Flórez, Sandra Pisonero-Vaquero, José Luis Olcoz, Ramiro Jover, Javier González-Gallego, María Victoria García-Mediavilla, Sonia Sánchez-Campos. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Free Radical Biology and Medicine 2017; 102: 188 doi: 10.1016/j.freeradbiomed.2016.11.037
|
| 39 |
Sarha A. L. Queiroz, Alyne M. M. Ton, Thiago M. C. Pereira, Bianca P. Campagnaro, Larissa Martinelli, Aitor Picos, Manuel Campos-Toimil, Elisardo C. Vasquez. The Gut Microbiota-Brain Axis: A New Frontier on Neuropsychiatric Disorders. Frontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.872594
|
| 40 |
Ruiguang Ma, Qian Li, Guoxian Yu, Jun Wang, Yueyue Li, Xinyan Xu, Yiqing Zhu, Min Dong, Yanjing Gao, Lixiang Li, Zhen Li. A multi-omics study to investigate the progression of the Correa pathway in gastric mucosa in the context of cirrhosis. Gut Pathogens 2023; 15(1) doi: 10.1186/s13099-023-00571-y
|
| 41 |
Guanhong Xue, Zhijie Zheng, Xiaoben Liang, Yonghui Zheng, Haichong Wu, Yunhe Fu. Uterine Tissue Metabonomics Combined with 16S rRNA Gene Sequencing To Analyze the Changes of Gut Microbiota in Mice with Endometritis and the Intervention Effect of Tau Interferon. Microbiology Spectrum 2023; 11(3) doi: 10.1128/spectrum.00409-23
|
| 42 |
Xiao Wei, Shan Jiang, Yuye Chen, Xiangna Zhao, Huan Li, Weishi Lin, Boxing Li, Xuesong Wang, Jing Yuan, Yansong Sun. Cirrhosis related functionality characteristic of the fecal microbiota as revealed by a metaproteomic approach. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0534-0
|
| 43 |
Andrei Voiosu, Signe Wiese, Theodor Voiosu, Flemming Bendtsen, Søren Møller. Bile acids and cardiovascular function in cirrhosis. Liver International 2017; 37(10): 1420 doi: 10.1111/liv.13394
|
| 44 |
Shukai Zhan, Na Li, Caiguang Liu, Ren Mao, Dongxuan Wu, Tong Li, Minhu Chen, Xiaojun Zhuang, Zhirong Zeng. Intestinal Fibrosis and Gut Microbiota: Clues From Other Organs. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.694967
|
| 45 |
Jiayin Liu, Chenxin Wang, Yushu Xiao. The influence and therapeutic effect of dietary pattern on liver diseases in the United State. Highlights in Science, Engineering and Technology 2022; 2: 54 doi: 10.54097/hset.v2i.555
|
| 46 |
Youyi Zhao, Sanxing Ma, Lirong Liang, Shuhui Cao, Ze Fan, Danyi He, Xiaotong Shi, Yao Zhang, Bing Liu, Meiting Zhai, Shengxi Wu, Fang Kuang, Hui Zhang. Gut Microbiota–Metabolite–Brain Axis Reconstitution Reverses Sevoflurane-Induced Social and Synaptic Deficits in Neonatal Mice. Research 2024; 7 doi: 10.34133/research.0482
|
| 47 |
Yuki Iizuka, Mayu Hikone, Yusuke Shimizu, Maki Tanabe, Kazuhiro Sugiyama, Yuichi Hamabe. Intestinal evisceration and Staphylococcus aureus bacteremia due to ruptured umbilical hernia in a patient with liver cirrhosis: a case report and literature review. Oxford Medical Case Reports 2022; 2022(7) doi: 10.1093/omcr/omac078
|
| 48 |
Junli Ma, Qihang Zhou, Houkai Li. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy. Nutrients 2017; 9(10): 1124 doi: 10.3390/nu9101124
|
| 49 |
Gut–organ axis: a microbial outreach and networking. Letters in Applied Microbiology 2021; 72(6): 636 doi: 10.1111/lam.13333
|
| 50 |
Xia Liu, Runzhou Sun, Zhaozhen Li, Ruixin Xiao, Pengfei Lv, Xiangrong Sun, Mark A. Olson, Yanling Gong. Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis. Archives of Biochemistry and Biophysics 2021; 711: 109019 doi: 10.1016/j.abb.2021.109019
|
| 51 |
Antonella Borrelli, Patrizia Bonelli, Franca Maria Tuccillo, Ira D. Goldfine, Joseph L. Evans, Franco Maria Buonaguro, Aldo Mancini. Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches. Redox Biology 2018; 15: 467 doi: 10.1016/j.redox.2018.01.009
|
| 52 |
Cassandra Francella, Jane A. Foster. Burger's Medicinal Chemistry and Drug Discovery. 2021; : 1 doi: 10.1002/0471266949.bmc297
|
| 53 |
Alphus Dan Wilson, Lisa Beth Forse. Development of Electronic-Nose Technologies for Early Disease Detection Based on Microbial Dysbiosis. 5th International Electronic Conference on Sensors and Applications 2018; : 32 doi: 10.3390/ecsa-5-05832
|
| 54 |
Man Chen, Junping Zheng, Xiaojuan Zou, Cheng Ye, Hui Xia, Ming Yang, Qinghua Gao, Qingxiong Yang, Hongtao Liu. Ligustrum robustum (Roxb.) blume extract modulates gut microbiota and prevents metabolic syndrome in high-fat diet-fed mice. Journal of Ethnopharmacology 2021; 268: 113695 doi: 10.1016/j.jep.2020.113695
|
| 55 |
Zidong Donna Fu, Julia Yue Cui. Remote Sensing Between Liver and Intestine: Importance of Microbial Metabolites. Current Pharmacology Reports 2017; 3(3): 101 doi: 10.1007/s40495-017-0087-0
|
| 56 |
Annette Bellar, Nicole Welch, Srinivasan Dasarathy. Exercise and physical activity in cirrhosis: opportunities or perils. Journal of Applied Physiology 2020; 128(6): 1547 doi: 10.1152/japplphysiol.00798.2019
|
| 57 |
Morten D. Jensen, Peter Jepsen, Hendrik Vilstrup, Lisbet Grønbæk. Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort Study. American Journal of Gastroenterology 2022; 117(1): 129 doi: 10.14309/ajg.0000000000001525
|
| 58 |
Michael Doulberis, Georgios Kotronis, Dimitra Gialamprinou, Jannis Kountouras, Panagiotis Katsinelos. Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota. Metabolism 2017; 71: 182 doi: 10.1016/j.metabol.2017.03.013
|
| 59 |
Akika Fukawa, Shunsuke Baba, Kaori Iwasawa, Makoto Yamaguchi, Akira Hosono. Dietary α-Lactalbumin protects against thioacetamide-induced liver cirrhosis by maintaining gut-liver axis function in rats. Bioscience, Biotechnology, and Biochemistry 2020; 84(1): 171 doi: 10.1080/09168451.2019.1660613
|
| 60 |
Makoto Matsushita, Kazutoshi Fujita, Koji Hatano, Marco A. De Velasco, Hirotsugu Uemura, Norio Nonomura. Connecting the Dots Between the Gut–IGF-1–Prostate Axis: A Role of IGF-1 in Prostate Carcinogenesis. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.852382
|
| 61 |
Tao Yang, Qijie Guan, Jin-Song Shi, Zheng-Hong Xu, Yan Geng. Metformin alleviates liver fibrosis in mice by enriching Lactobacillus sp. MF-1 in the gut microbiota. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2023; 1869(5): 166664 doi: 10.1016/j.bbadis.2023.166664
|
| 62 |
Feng-Ping Bai, Jian Tang, Xiao-Xiao Liao, Zhi-Xiong Jiang. Research progress on probiotics and prebiotics in the treatment of nonalcoholic fatty liver disease. Journal of Nutritional Oncology 2025; 10(2): 40 doi: 10.1097/JN9.0000000000000050
|
| 63 |
Michael X. Chen, San-Yuan Wang, Ching-Hua Kuo, I-Lin Tsai. Metabolome analysis for investigating host-gut microbiota interactions. Journal of the Formosan Medical Association 2019; 118: S10 doi: 10.1016/j.jfma.2018.09.007
|
| 64 |
Saba Sadeghirashed, Fatemeh Kazemi, Saba Taheri, Maryam Tajabadi Ebrahimi, Javad Arasteh. A novel probiotic strain exerts therapeutic effects on mouse model of multiple sclerosis by altering the expression of inflammasome and IDO genes and modulation of T helper cytokine profile. Metabolic Brain Disease 2022; 37(1): 197 doi: 10.1007/s11011-021-00857-7
|
| 65 |
Natalia Nuño-Lámbarri, Norberto C. Chávez-Tapia, Misael Uribe. Encyclopedia of Food Chemistry. 2019; : 387 doi: 10.1016/B978-0-08-100596-5.21759-9
|
| 66 |
Yingying Zhao, Song Yang, Huichun Xing. Pulmonary Bacterial Infection and Liver Cirrhosis: Current Status and Treatment. Infectious Microbes and Diseases 2023; doi: 10.1097/IM9.0000000000000137
|
| 67 |
Mengmeng Shao, Yi Zhu. Long-term metal exposure changes gut microbiota of residents surrounding a mining and smelting area. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-61143-7
|
| 68 |
Yajing Shi, Yufang Leng, Disheng Liu, Xin Liu, Yixing Ren, Jianmin Zhang, Feng Chen. Research Advances in Protective Effects of Ursolic Acid and Oleanolic Acid Against Gastrointestinal Diseases. The American Journal of Chinese Medicine 2021; 49(02): 413 doi: 10.1142/S0192415X21500191
|
| 69 |
Xiu Sun, Calvin Q. Pan, Huichun Xing. Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection. Hepatology International 2021; 15(5): 1053 doi: 10.1007/s12072-021-10230-6
|
| 70 |
Yasushi Okura, Tadashi Namisaki, Shinya Sato, Kei Moriya, Takemi Akahane, Mitsuteru Kitade, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Yasuhiko Sawada, Naotaka Shimozato, Kenichiro Seki, Soichiro Saikawa, Keisuke Nakanishi, Masanori Furukawa, Yukihisa Fujinaga, Takuya Kubo, Daisuke Kaya, Yuki Tsuji, Takahiro Ozutsumi, Koh Kitagawa, Tsuyoshi Mashitani, Hiroyuki Ogawa, Koji Ishida, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji. Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis. Hepatology Research 2019; 49(2): 232 doi: 10.1111/hepr.13249
|
| 71 |
Hua Zha, Yanfei Chen, Jieyun Wu, Kevin Chang, Yanmeng Lu, Hua Zhang, Jiaojiao Xie, Qiangqiang Wang, Ruiqi Tang, Lanjuan Li. Characteristics of Three Microbial Colonization States in the Duodenum of the Cirrhotic Patients. Future Microbiology 2020; 15(10): 855 doi: 10.2217/fmb-2019-0270
|
| 72 |
Neil Daniel, Flavia Genua, Mazda Jenab, Ana-Lucia Mayén, Anastasia Chrysovalantou Chatziioannou, Pekka Keski-Rahkonen, David J. Hughes. The role of the gut microbiome in the development of hepatobiliary cancers. Hepatology 2024; 80(5): 1252 doi: 10.1097/HEP.0000000000000406
|
| 73 |
Yutong Fu, Qianqian Wang, Yongpeng Guo, Matthew Koci, Zhengda Lu, Xiangfang Zeng, Yanan Wang, Yu Tang, Qiugang Ma, Cheng Ji, Lihong Zhao. Pleurotus eryngii polysaccharides alleviate aflatoxin B1-induced liver inflammation in ducks involving in remodeling gut microbiota and regulating SCFAs transport via the gut-liver axis. International Journal of Biological Macromolecules 2024; 271: 132371 doi: 10.1016/j.ijbiomac.2024.132371
|
| 74 |
Maria Adriana Neag, Andrei Otto Mitre, Adrian Catinean, Anca Dana Buzoianu. Overview of the microbiota in the gut-liver axis in viral B and C hepatitis. World Journal of Gastroenterology 2021; 27(43): 7446-7461 doi: 10.3748/wjg.v27.i43.7446
|
| 75 |
Haruka Sagi, Shuichi Shibuya, Tamotsu Kato, Yumiko Nakanishi, Arisa Tsuboi, Shigeharu Moriya, Hiroshi Ohno, Hirokuni Miyamoto, Hiroaki Kodama, Takahiko Shimizu. SOD1 deficiency alters gastrointestinal microbiota and metabolites in mice. Experimental Gerontology 2020; 130: 110795 doi: 10.1016/j.exger.2019.110795
|
| 76 |
Wenwen Zhao, Meng Xiao, Jie Yang, Li Zhang, Yinying Ba, Rongrong Xu, Zongyang Liu, Haiyan Zou, Ping Yu, Xia Wu, Xiaoqing Chen. The combination of Ilexhainanoside D and ilexsaponin A1 reduces liver inflammation and improves intestinal barrier function in mice with high-fat diet-induced non-alcoholic fatty liver disease. Phytomedicine 2019; 63: 153039 doi: 10.1016/j.phymed.2019.153039
|
| 77 |
Rui-Yuan Pan, Jing Zhang, Jinlei Wang, Yingyi Wang, Zhihui Li, Yang Liao, Yajin Liao, Chenggang Zhang, Zhiqiang Liu, Lijuan Song, Jiezhong Yu, Zengqiang Yuan. Intermittent fasting protects against Alzheimer’s disease in mice by altering metabolism through remodeling of the gut microbiota. Nature Aging 2022; 2(11): 1024 doi: 10.1038/s43587-022-00311-y
|
| 78 |
You-Tae Kim, David A. Mills. Exploring the gut microbiome: probiotics, prebiotics, synbiotics, and postbiotics as key players in human health and disease improvement. Food Science and Biotechnology 2024; 33(9): 2065 doi: 10.1007/s10068-024-01620-1
|
| 79 |
Suraphan Panyod, Wei-Kai Wu, Chieh-Chang Chen, Ming-Shiang Wu, Chi-Tang Ho, Lee-Yan Sheen. Modulation of gut microbiota by foods and herbs to prevent cardiovascular diseases. Journal of Traditional and Complementary Medicine 2023; 13(2): 107 doi: 10.1016/j.jtcme.2021.09.006
|
| 80 |
Zeinab Ashour, Rasha Shahin, Zeinab Ali-Eldin, Mohamed El-Shayeb, Tarek El-Tayeb, Salwa Bakr. Potential impact of gut Lactobacillus acidophilus and Bifidobacterium bifidum on hepatic histopathological changes in non-cirrhotic hepatitis C virus patients with different viral load. Gut Pathogens 2022; 14(1) doi: 10.1186/s13099-022-00501-4
|
| 81 |
Ankita Chatterjee, Priyadarshi Basu. Nutrition and Functional Foods in Boosting Digestion, Metabolism and Immune Health. 2022; : 99 doi: 10.1016/B978-0-12-821232-5.00023-9
|
| 82 |
Yuyan Feng, Wenqing Mei, Qu Chen, Xiaojing Chen, Yingdong Ni, Mingming Lei, Jie Liu. Probiotic Supplementation Alleviates Corticosterone-Induced Fatty Liver Disease by Regulating Hepatic Lipogenesis and Increasing Gut Microbiota Diversity in Broilers. Microorganisms 2025; 13(1): 200 doi: 10.3390/microorganisms13010200
|
| 83 |
Sergio Salgüero, David Rojo, Juan Berenguer, Juan González‐García, Amanda Fernández‐Rodríguez, Oscar Brochado‐Kith, Cristina Díez, Victor Hontañon, Ana Virseda‐Berdices, Javier Martínez, Luis Ibañez‐Samaniego, Elba Llop‐Herrera, Coral Barbas, Salvador Resino, María A. Jiménez‐Sousa. Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV‐coinfected and HCV‐monoinfected patients. Liver International 2020; 40(9): 2215 doi: 10.1111/liv.14580
|
| 84 |
Qian Chen, Chunxia Mei, Min Guo, Botao Wang, Haiqin Chen, Jianxin Zhao, Gang Wang, Wei Chen.
Lactobacillus plantarum CCFM1180 attenuates obesity induced by estrogen deficiency by activating estrogen receptor alpha in abdominal adipose tissue and regulating gut microbiota-derived metabolites
. Food Science and Human Wellness 2024; 13(2): 765 doi: 10.26599/FSHW.2022.9250065
|
| 85 |
Nonalcoholic Steatohepatitis: Case-Based Focused on Pediatric and Adult Guidelines. Osteopathic Family Physician 2021; 13(2): 29 doi: 10.33181/13024
|
| 86 |
Yanbo Kou, Shenghan Zhang, Junru Chen, Yusi Shen, Zhiwei Zhang, Haohan Huang, Yulu Ma, Yaoyao Xiang, Longxiang Liao, Junyang Zhou, Wanpeng Cheng, Yuan Zhou, Huan Yang, Zhuanzhuan Liu, Yanxia Wei, Hui Wang, Yugang Wang. A mouse protozoan boosts antigen-specific mucosal IgA responses in a specific lipid metabolism- and signaling-dependent manner. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-52336-z
|
| 87 |
Xiaopei Liu, Dan Liu, Cong’e Tan, Wenzhe Feng. Gut microbiome-based machine learning for diagnostic prediction of liver fibrosis and cirrhosis: a systematic review and meta-analysis. BMC Medical Informatics and Decision Making 2023; 23(1) doi: 10.1186/s12911-023-02402-1
|
| 88 |
Effect of dark environment on intestinal flora and expression of genes related to liver metabolism in zebrafish (Danio rerio). Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 2021; 249: 109100 doi: 10.1016/j.cbpc.2021.109100
|
| 89 |
Shouquan Wu, Minggui Wang, Miaomiao Zhang, Jian-Qing He. Metabolomics and microbiomes for discovering biomarkers of antituberculosis drugs-induced hepatotoxicity. Archives of Biochemistry and Biophysics 2022; 716: 109118 doi: 10.1016/j.abb.2022.109118
|
| 90 |
Naeem Ullah, Mian Adnan Kakakhel, Israr Khan, Mian Gul Hilal, Zha Lajia, Yanrui Bai, Wasim Sajjad, Li Yuxi, Habib Ullah, Hailah M. Almohaimeed, Faisal Al-Sarraj, Rasha Assiri, Waheeb S. Aggad, Nada Abdullah Alharbi, Areej Mohammed Alshehri, Guanlan Liu, Hui Sun, Chunjiang Zhang. Structural and compositional segregation of the gut microbiota in HCV and liver cirrhotic patients: A clinical pilot study. Microbial Pathogenesis 2022; 171: 105739 doi: 10.1016/j.micpath.2022.105739
|
| 91 |
A Roda, R Aldini, C Camborata, S Spinozzi, P Franco, M Cont, A D'Errico, F Vasuri, A Degiovanni, L Maroni, L Adorini. Metabolic Profile of Obeticholic Acid and Endogenous Bile Acids in Rats with Decompensated Liver Cirrhosis. Clinical and Translational Science 2017; 10(4): 292 doi: 10.1111/cts.12468
|
| 92 |
Susanne Feder, Reiner Wiest, Thomas S. Weiss, Charalampos Aslanidis, Doris Schacherer, Sabrina Krautbauer, Gerhard Liebisch, Christa Buechler. Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels are not associated with severity of liver disease and are inversely related to cholesterol in a cohort of thirty eight patients with liver cirrhosis. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01431-x
|
| 93 |
Brittni N. Moore, Jennifer L. Pluznick. Commensal microbiota regulate renal gene expression in a sex-specific manner. American Journal of Physiology-Renal Physiology 2023; 324(6): F511 doi: 10.1152/ajprenal.00303.2022
|
| 94 |
Guole Nie, Honglong Zhang, Danna Xie, Jun Yan, Xun Li. Liver cirrhosis and complications from the perspective of dysbiosis. Frontiers in Medicine 2024; 10 doi: 10.3389/fmed.2023.1320015
|
| 95 |
Yuchen Wang, Bashar M. Attar, Rohit Agrawal, Ishaan Vohra, Muhammad Zain Farooq, Sheeba Ba Aqeel, Melchor Demetria. Non-hepatic Cancers Independently Predict Liver Decompensation Events. Journal of Gastrointestinal Cancer 2021; 52(2): 523 doi: 10.1007/s12029-020-00409-9
|
| 96 |
K. S. Gala, E. Winrich, S. K. Jha, R. Parthasarathy, V. Vatsalya. Alcohol Use Disorder and the Gut Microbiome. Current Addiction Reports 2023; 11(1): 105 doi: 10.1007/s40429-023-00527-x
|
| 97 |
Themistoklis Kourkoumpetis, Gagan Sood. Pathogenesis of Alcoholic Liver Disease. Clinics in Liver Disease 2019; 23(1): 71 doi: 10.1016/j.cld.2018.09.006
|
| 98 |
Marta Ramirez, Nuria Pell, Marc Mejias, Mercedes Fernandez. Pericyte Biology in Different Organs. Advances in Experimental Medicine and Biology 2019; 1122: 73 doi: 10.1007/978-3-030-11093-2_5
|
| 99 |
Juan Dai, Xiao Yang, Ya Yuan, Youzhen Jia, Guibing Liu, Nan Lin, Hang Xiao, Lishi Zhang, Jinyao Chen. Toxicity, gut microbiota and metabolome effects after copper exposure during early life in SD rats. Toxicology 2020; : 152395 doi: 10.1016/j.tox.2020.152395
|
| 100 |
Nasrin Motazedian, Amirali Mashhadiagha, Seyed Ali Moosavi, Seyed Mohsen Dehghani, Mehrab Sayadi, Ahmad Gholami, Negar Azarpira. Effects of <i>Lactobacillus sporogenesis</i> on Pediatric Cholestatic Liver Disease: A Randomized, Triple-Blind, Placebo-Controlled Trial. Innovative Journal of Pediatrics 2025; 35(3) doi: 10.5812/ijpediatr-153706
|
| 101 |
Hiroshi Fukui. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?. Diseases 2019; 7(4): 58 doi: 10.3390/diseases7040058
|
| 102 |
Xiaoli Zhang, Yunpeng Dong, Guoying Sun, Ahmed A. Hasan, Mei Tian, Suimin Zeng, Jing Li, Shiyu Zeng, Jun Ma, Jian Li, Berthold Hocher. Paternal Programming of Liver Function and Lipid Profile Induced by a Paternal Pre-Conceptional Unhealthy Diet: Potential Association with Altered Gut Microbiome Composition. Kidney and Blood Pressure Research 2019; 44(1): 133 doi: 10.1159/000497487
|
| 103 |
Yaowen Chen, Pu Liu, Runyan Liu, Shuofeng Hu, Zhen He, Guohua Dong, Chao Feng, Sijing An, Xiaomin Ying, Jian Xu. Comprehensive Strain-Level Analysis of the Gut Microbe Faecalibacterium prausnitzii in Patients with Liver Cirrhosis. mSystems 2021; 6(4) doi: 10.1128/msystems.00775-21
|
| 104 |
Yue PU, Xinxiang ZHANG, Juan ZHANG, Daojun XIE, Han WANG, Hong CHEN, Ying MA, Nian PENG, Rui LI, Hao YE. Correlation between differences in the intestinal flora structure and Chinese medicine evidence in patients with Wilson disease-related liver fibrosis analyzed via high-throughput sequencing technology. Bioscience of Microbiota, Food and Health 2025; 44(2): 146 doi: 10.12938/bmfh.2024-081
|
| 105 |
Dana Tedesco, Manoj Thapa, Chui Yoke Chin, Yong Ge, Minghao Gong, Jing Li, Sanjeev Gumber, Patrick Speck, Elizabeth J. Elrod, Eileen M. Burd, William H. Kitchens, Joseph F. Magliocca, Andrew B. Adams, David S. Weiss, Mansour Mohamadzadeh, Arash Grakoui. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor–Positive Cells and Pathogenesis of Cholestatic Liver Disease. Gastroenterology 2018; 154(8): 2178 doi: 10.1053/j.gastro.2018.02.019
|